| Product Code: ETC12773061 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China NSCLC Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China NSCLC Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China NSCLC Therapeutics Market - Industry Life Cycle |
3.4 China NSCLC Therapeutics Market - Porter's Five Forces |
3.5 China NSCLC Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China NSCLC Therapeutics Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 China NSCLC Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China NSCLC Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China NSCLC Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 High incidence of non-small cell lung cancer (NSCLC) in China |
4.2.2 Increasing adoption of targeted therapies and immunotherapies |
4.2.3 Growing awareness about early diagnosis and treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High cost associated with advanced NSCLC treatments |
4.3.3 Limited access to specialized healthcare facilities in rural areas |
5 China NSCLC Therapeutics Market Trends |
6 China NSCLC Therapeutics Market, By Types |
6.1 China NSCLC Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China NSCLC Therapeutics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 China NSCLC Therapeutics Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 China NSCLC Therapeutics Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021 - 2031F |
6.1.5 China NSCLC Therapeutics Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.6 China NSCLC Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2 China NSCLC Therapeutics Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 China NSCLC Therapeutics Market Revenues & Volume, By Pembrolizumab, 2021 - 2031F |
6.2.3 China NSCLC Therapeutics Market Revenues & Volume, By Erlotinib, 2021 - 2031F |
6.2.4 China NSCLC Therapeutics Market Revenues & Volume, By Cisplatin, 2021 - 2031F |
6.2.5 China NSCLC Therapeutics Market Revenues & Volume, By Stereotactic Body Radiation, 2021 - 2031F |
6.3 China NSCLC Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China NSCLC Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China NSCLC Therapeutics Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 China NSCLC Therapeutics Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.3.5 China NSCLC Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 China NSCLC Therapeutics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China NSCLC Therapeutics Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.3 China NSCLC Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.4 China NSCLC Therapeutics Market Revenues & Volume, By Advanced Cancer Treatment, 2021 - 2031F |
6.4.5 China NSCLC Therapeutics Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
7 China NSCLC Therapeutics Market Import-Export Trade Statistics |
7.1 China NSCLC Therapeutics Market Export to Major Countries |
7.2 China NSCLC Therapeutics Market Imports from Major Countries |
8 China NSCLC Therapeutics Market Key Performance Indicators |
8.1 Patient survival rates after receiving specific NSCLC therapies |
8.2 Number of clinical trials for NSCLC therapeutics conducted in China |
8.3 Percentage of NSCLC patients diagnosed at early stages |
8.4 Adoption rate of targeted therapies and immunotherapies for NSCLC |
8.5 Availability and utilization of support services for NSCLC patients |
9 China NSCLC Therapeutics Market - Opportunity Assessment |
9.1 China NSCLC Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China NSCLC Therapeutics Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 China NSCLC Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China NSCLC Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China NSCLC Therapeutics Market - Competitive Landscape |
10.1 China NSCLC Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China NSCLC Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here